A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2006
11/30/2006	DE202006013847U1 Alpha-liponic acid composition, useful e.g. in the treatment of diabetic retinopathy, comprises chromic compound and isoflavon(e)
11/30/2006	CA2611102A1 Method to treat and prevent posterior capsule opacification
11/30/2006	CA2609659A1 Azanaphthalenes, compositions and methods for treating retinal disease
11/30/2006	CA2609549A1 Treatment of eye disorders with sirtuin modulators
11/29/2006	EP1480624B1 Pharmaceutical tablet
11/29/2006	EP1313504B1 Methods and compositions for inhibiting angiogenesis
11/29/2006	EP1259223A4 Protein matrix materials, devices and methods of making and using thereof
11/29/2006	EP1248804B1 Recombinant antibodies to human interleukin-1 beta
11/29/2006	EP1162999B1 Vaccine against Streptococcus pneumoniae
11/29/2006	EP1021406B1 Novel anandamide amidase inhibitors as analgesic agents
11/29/2006	CN1871029A Drug containing chymase inhibitor as the active ingredient
11/29/2006	CN1871014A Pharmaceutical composition containing prostaglandin
11/29/2006	CN1870997A Treatment agent for keratoconjunctival disorder
11/29/2006	CN1870989A Coumarin derivative for treatment of ophthalmic disorders
11/29/2006	CN1868523A Medicine composition for treating eye disease, and its use
11/29/2006	CN1868449A Ganciclovir ophthalmic gel and its prepn. method
11/29/2006	CN1868332A Health-care food with function of anti vision fatigue syndrome
11/29/2006	CN1286844C Medicinal composition containing angiotensin II receptor antagonist and vitamin B
11/29/2006	CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
11/29/2006	CN1286471C Calf blood deproteinated extract, its eye ointment preparation and its preparing method
11/28/2006	US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
11/28/2006	CA2379786C Purine derivatives
11/28/2006	CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/28/2006	CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006	CA2268305C Use of an h+, k+-atpase inhibitor in the treatment of nasal polyps
11/23/2006	WO2006124862A2 Methods for the treatment of ocular and neurodegenerative conditions in a mammal
11/23/2006	WO2006123676A1 Prophylactic or therapeutic agent for corneal and conjunctival disorder
11/23/2006	WO2006123675A1 Protective agent for neurocyte comprising amidino derivative as active ingredient
11/23/2006	WO2006123674A1 Angiogenesis inhibitor containing amine derivative as active ingredient
11/23/2006	WO2006123639A1 Pyrimidine derivative
11/23/2006	WO2006123466A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006098918A3 Substituted gamma lactams as therapeutic agents
11/23/2006	US20060264516 Use of low molecular weight amino alcohols in ophthalmic compositions
11/23/2006	US20060264508 Modulation of ocular growth and myopia by gaba drugs
11/23/2006	US20060264492 methyl [5(6)-(4-alanylaminophenylthio)-1H-benzimidazol-2yl]carbamate; for treating neovascularization, solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006	US20060264353 Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertension
11/23/2006	US20060263827 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances
11/23/2006	US20060263819 Diagnostics and therapeutics for macular degeneration-related disorders
11/23/2006	US20060263409 Treatment of ocular disease
11/23/2006	US20060263392 Method for treating neovascularization
11/22/2006	EP1724278A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1723954A1 Indazole derivatives for the treatment of cancer
11/22/2006	EP1722795A1 Piperidinyl prostaglandin e analogs
11/22/2006	EP1722780A1 A method of preventing or treating glaucoma
11/22/2006	EP1467982B1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
11/22/2006	EP1360186B1 Carboline derivatives
11/22/2006	EP1173465B1 Novel human voltage-gated potassium channel
11/22/2006	EP1120114B1 Compositions and methods for treating conditions responsive to estrogen
11/22/2006	EP1080070B1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/22/2006	CN1864688A Agent for preventing and treating glaucoma
11/22/2006	CN1864546A A Chinese wolfberry cake and preparation process thereof
11/22/2006	CN1285580C Pyrimidine compounds
11/22/2006	CN1285578C Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
11/22/2006	CN1285572C Cannabinod receptor ligands
11/22/2006	CN1285363C Chinese and western compound medicinal eye drop for treating eyeball congestion disease
11/22/2006	CN1285349C Chinese medicinal formulation for treating asthenopia syndrome and its preparation method
11/21/2006	US7138542 Administering a therapeutically effective amount of an alpha2delta ligand other than gabapentin or tiagabine, or pharmaceutically acceptable salt thereof
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138420 Substituted benzimidazole compounds
11/21/2006	US7138417 Inhibitors of integrin αvβ6
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006	CA2478621C Botulinum toxin pharmaceutical compositions
11/21/2006	CA2334843C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/21/2006	CA2247257C Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
11/18/2006	CA2547251A1 Fused pyrazolyl compounds for cancer treatment
11/16/2006	WO2006121822A1 USE OF β-LACTAMS FOR THE TREATMENTOF IBD AND GLAUCOMA
11/16/2006	WO2006121363A1 Eslicarbazepine acetate and methods of use
11/16/2006	WO2006050837A3 Ophthalmic emulsions containing an immunosuppressive agent
11/16/2006	US20060258726 1,5-Disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
11/16/2006	US20060258707 Benzimidazolidinone derivatives as muscarinic agents
11/16/2006	US20060258703 Remedy for pruritus comprising piperidine derivative as the active ingredient
11/16/2006	US20060258701 glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus; 3-(4-methoxy-phenylsulfanyl)-6-(4H-[1,2,4]triazol-3-yl-sulfanyl)-N-([1,3,4]thiadiazol-2-yl)-2-pyridine carboxamide
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258652 Beta-blockers having antioxidant and no-donor activity
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257418 Vaccine
11/16/2006	US20060257351 administering, to a subject a formulation containing2-(3,4-dihydroxyphenyl)ethanol or a glucoside; and cysteine or cystine for potentiating glutathione, for promoting the production of a gamma -glutamylcysteine synthetase, glutathione reductase; antiaging agents, nutraceuticals, sunscreen agents
11/16/2006	US20060257330 Powdery pharmaceutical compositions for inhalation
11/16/2006	CA2607181A1 A non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
11/15/2006	EP1721905A1 Thiazole derivative
11/15/2006	EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006	EP1720555A1 Tetracycline derivatives for the treatment of ocular pathologies
11/15/2006	EP1720537A2 Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
11/15/2006	EP1511482B1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	EP1309323B1 Treatment of angiogenesis-related disorders using benzoyl phenylacetic acid derivatives
11/15/2006	EP1208214B1 Genetically engineered bleb vaccine

1 ... 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 ... 531